142 related articles for article (PubMed ID: 35643255)
21. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers.
Reshko LB; Baliga S; Crandley EF; Harry Lomas IV; Richardson MK; Spencer K; Bennion N; Mikdachi HE; Irvin W; Kersh CR
Gynecol Oncol; 2020 Dec; 159(3):611-617. PubMed ID: 33059914
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic body radiotherapy for oligometastatic soft tissue sarcoma.
Loi M; Duijm M; Baker S; Rossi L; Grunhagen D; Verhoef C; Nuyttens J
Radiol Med; 2018 Nov; 123(11):871-878. PubMed ID: 29923086
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic body radiation therapy for sarcoma pulmonary metastases.
Lebow ES; Lobaugh SM; Zhang Z; Dickson MA; Rosenbaum E; D'Angelo SP; Nacev BA; Shepherd AF; Shaverdian N; Wolden S; Wu AJ; Gelblum DY; Simone CB; Gomez DR; Alektiar K; Tap WD; Rimner A
Radiother Oncol; 2023 Oct; 187():109824. PubMed ID: 37532104
[TBL] [Abstract][Full Text] [Related]
25. Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.
Nelson DB; Tayob N; Nguyen QN; Erasmus J; Mitchell KG; Hofstetter WL; Sepesi B; Antonoff MB; Mehran RJ
J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1234-1241.e16. PubMed ID: 31395367
[TBL] [Abstract][Full Text] [Related]
26. A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
Kimura T; Takeda A; Tsurugai Y; Kawano R; Doi Y; Oku Y; Hioki K; Miura H; Nagata Y
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1265-1275. PubMed ID: 32712256
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.
Trovo M; Minatel E; Durofil E; Polesel J; Avanzo M; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Rumeileh IA; Trovo MG
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1114-9. PubMed ID: 24661664
[TBL] [Abstract][Full Text] [Related]
28. Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.
Sittenfeld SMC; Juloori A; Reddy CA; Stephans KL; Videtic GMM
Clin Lung Cancer; 2021 May; 22(3):e360-e365. PubMed ID: 32624412
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer.
Giuliani M; Hope A; Guckenberger M; Mantel F; Peulen H; Sonke JJ; Belderbos J; Werner-Wasik M; Ye H; Grills IS
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):893-899. PubMed ID: 28258901
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity.
Greto D; Loi M; Stocchi G; Salvestrini V; Muratori F; Scoccianti G; Roselli G; Palomba A; Lorenzetti V; Cerbai C; Desideri I; Francolini G; Bonomo P; Campanacci DA; Livi L
Cancer J; 2021 Nov-Dec 01; 27(6):423-427. PubMed ID: 34904803
[TBL] [Abstract][Full Text] [Related]
33. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
Leeman JE; Bilsky M; Laufer I; Folkert MR; Taunk NK; Osborne JR; Arevalo-Perez J; Zatcky J; Alektiar KM; Yamada Y; Spratt DE
J Neurosurg Spine; 2016 Jul; 25(1):52-8. PubMed ID: 26943256
[TBL] [Abstract][Full Text] [Related]
35. Patterns of local recurrence and dose fractionation of adjuvant radiation therapy in 462 patients with soft tissue sarcoma of extremity and trunk wall.
Jebsen NL; Engellau J; Engström K; Bauer HC; Monge OR; Muren LP; Eide GE; Trovik CS; Bruland OS
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):949-55. PubMed ID: 23725998
[TBL] [Abstract][Full Text] [Related]
36. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT).
Reyngold M; Wu AJ; McLane A; Zhang Z; Hsu M; Stein NF; Zhou Y; Ho AY; Rosenzweig KE; Yorke ED; Rimner A
Radiat Oncol; 2013 Apr; 8():99. PubMed ID: 23617949
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation.
Kelly P; Balter PA; Rebueno N; Sharp HJ; Liao Z; Komaki R; Chang JY
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1387-93. PubMed ID: 20381271
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
[TBL] [Abstract][Full Text] [Related]
39. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
40. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
